| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents... | Educational Intervention, Internet-Based Intervention, Laboratory Biomarker Analysis, Medical Device Usage and Evaluation, Quality-of-Life Assessment, Questionnaire Administration | NCT03223753 | Children's Oncology Group | Recruiting |
| Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers | Placebo, Sulforaphane | NCT03232138 | Jian-Min Yuan, MD | Active, not recruiting |
| Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer | Digital Mammography, Digital Tomosynthesis Mammography, Laboratory Biomarker Analysis | NCT03233191 | ECOG-ACRIN Cancer Research Group | Recruiting |
| Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic... | Best Practice, Laboratory Biomarker Analysis, Supportive Care | NCT03253848 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer | Bio-Specimen Collection | NCT03260842 | Stanford University | Recruiting |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis | Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration | NCT03278925 | National Cancer Institute (NCI) | Active, not recruiting |
| Lifestyle Change for Better Health | Dietary Intervention, Physical Activity Intervention | NCT03286699 | University of Pittsburgh | Active, not recruiting |
| Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... | Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration | NCT03300557 | National Cancer Institute (NCI) | Active, not recruiting |
| MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine | NCT03300817 | National Cancer Institute (NCI) | Active, not recruiting |
| Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients | Biospecimen Collection, Laboratory Biomarker Analysis, Magnetic Resonance Imaging | NCT03303846 | City of Hope Medical Center | Recruiting |
Why I Joined a Clinical Trial
I enrolled in the trial, in part, because I wanted to be able to tell my future patients that, when given the opportunity to participate in a clinical trial, I did so. If I was fortunate enough to survive my malignancy, I felt that my personal involvement in a clinical trial strengthened my endorsement of clinical trial participation for my future patients. Patients should know that the focus of cancer-related investigation extends beyond traditional cancer-related endpoints and into the control of cancer- and treatment-related symptoms.